Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025STAFFORD, Texas, March 13, 2024 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial...
Globe Newswire•5 months ago